KKR Divests 32.8M Shares In Laureate Education Via Secondary Offering
Today, 2:01 AM
Laureate Education Inc (NASDAQ:LAUR) has priced the underwritten secondary offering by certain existing stockholders affiliated with Kohlberg Kravis Roberts & Co.…
Vertex Selling Stockholder Offloads Stock At 10% Discount
Today, 2:01 AM
Global provider of tax technology solutions Vertex, Inc (NASDAQ:VERX) priced 1.5 million shares by Jeffrey R. Westphal at $15.15 per…
Laureate Education Announces the Pricing of an Underwritten Public Offering by Selling Stockholders: 32,842,183 Shares At $9.75/Share
Today, 2:01 AM
Laureate Education, Inc. (NASDAQ:LAUR) (the "Company") today announced the pricing of the underwritten secondary offering by certain existing stockholders affiliated with Kohlberg Kravis Roberts & Co. L.P.
Reported Late Thursday, G1 Therapeutics Announces Pricing Of $50.05M Public Offering Of 7.7M Shares Of Common Stock At A Price Of $6.50/Share
Today, 2:01 AM
G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced the pricing of an underwritten public offering of 7,700,000 shares of its common stock at a public offering price
Reported Late Thursday, Vertex Announces Pricing Of Public Offering Of 1.5M Shares Of Class A Common Stock By Selling Stockholder At A Price Of $15.15/Share
Today, 2:01 AM
Vertex, Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), a global provider of tax technology solutions, announced today the pricing of an underwritten offering of 1,500,000 shares of its Class A common
Reported Late Thursday, 360 DigiTech Launches Global Offering Of 5.54M Class A Ordinary Shares
Today, 2:01 AM
360 DigiTech, Inc.
ToughBuilt Industries Announces~2.6M Share Offering Plus Warrants to Purchase Up to ~!0.6M Shares @~$2.86/Share
Today, 2:01 AM
ToughBuilt Industries, Inc.
360 DigiTech Announced Offering of. 5,540,000 Class A Ordinary Shares in 424B5 Filing
Today, 2:01 AM
https://www.sec.gov/Archives/edgar/data/1741530/000110465922119761/tm2228449-6_424b5.htm
RAPT Therapeutics Announces Proposed Public Offering Of $75M Of Common Stock
Today, 2:01 AM
RAPT Therapeutics, Inc. (NASDAQ:RAPT) ("RAPT" or the "Company"), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small